The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Nitric Oxide and Nitroxidative Stress in Alzheimer's Disease
Abstract
Nitric oxide is a signaling molecule produced by neurons and endothelial cells in the brain. NO is synthesized from L-arginine and oxygen by nitric oxide synthase: neuronal (nNOS), endothelial (eNOS), and inducible (iNOS). The endothelial NO acts as a vasorelaxant in the vasculature and as a neurotransmitter when produced by neurons (under the pathological conditions of Alzheimer's disease). NO can be scavenged in a rapid reaction with superoxide (O2-) to generate peroxynitrite (ONOO-), with a half-life of < 1 s. ONOO- is a potent oxidant and the primary component of nitroxidative stress. At high concentrations (> 100 nM), ONOO- can undergo homolytic or heterolytic cleavage to produce NO2+, NO2, and OH., highly reactive oxidative species and secondary components of nitroxidative stress. The high nitroxidative stress can initiate a cascade of redox reactions which can trigger apoptosis and evoke cytotoxic effects on neurons and endothelial cells. This article reviews the functions of NO and the potential role of NO/O2-/ONOO- induced nitroxidative stress in neuronal and endothelial degeneration observed in Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given the sensitivity of CM-H2DCFDA to oxidation by ONOO−, in combination with the propensity of ONOO− formation attributable to Aβ-induced stress, we reasoned that the primary RS detected in our paradigm was ONOO− (Setsukinai et al., 2003; Malinski, 2007).”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Malinski, 2007
In the citing paper
“Tyrosine nitration provides a footprint for free radical-mediated damage involving oxidation of NO· to ONOO− or products of its subsequent decomposition and the formation of a tyrosyl radical intermediate (Halliwell and Gutteridge, 2007; Malinski, 2007).”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Malinski, 2007
In the citing paper
“An imbalance between protective • NO and highly cytotoxic ONOO -may be crucial in the initial step of the development of several vascular and neuronal diseases, including AD (Malinski, 2007).”
From Multi-target neuroprotective effects of herbal medicines for Alzheimer's disease (2022) · cites this paper as Malinski, 2007
Citations
Cites
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Nitric oxide synthases: structure, function and inhibition
ALDERTON, W. K., COOPER, C. E., & KNOWLES, R. G. (2001) · Biochemical Journal · doi:10.1042/bj3570593 · Cited by 4,110
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114
Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor
Maliñski, T., & Taha, Z. (1992) · Nature · doi:10.1038/358676a0 · Cited by 1,071
Neurodegenerative diseases and oxidative stress
Emerit, J., Edeas, M. A., & Bricaire, F. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.11.004 · Cited by 1,057
Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death
Boje, K. M., & Arora, P. K. (1992) · Brain Research · doi:10.1016/0006-8993(92)91004-x · Cited by 944
A novel neuronal messenger molecule in brain: The free radical, nitric oxide
Dawson, T. M., Dawson, V. L., & Snyder, S. H. (1992) · Annals of Neurology · doi:10.1002/ana.410320302 · Cited by 828
Cited by
Sorted by citations
Excited-state intramolecular proton-transfer (ESIPT) based fluorescence sensors and imaging agents
Sedgwick, A. C., Wu, L., Han, H., Bull, S. D., He, X., James, T. D., Sessler, J. L., Tang, B. Z., Tian, H., & Yoon, J. (2018) · Chemical Society Reviews · doi:10.1039/c8cs00185e · Cited by 1,589
Fricker, M., Tolkovsky, A. M., Borutaitė, V., Coleman, M. P., & Brown, G. C. (2018) · Physiological Reviews · doi:10.1152/physrev.00011.2017 · Cited by 1,148
A review on cholinesterase inhibitors for Alzheimer’s disease
Anand, P., & Singh, B. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0036-3 · Cited by 722
Zhou, L., & Zhu, D. (2009) · Nitric Oxide · doi:10.1016/j.niox.2009.03.001 · Cited by 684
Therapeutic applications of compounds in the Magnolia family
Lee, Y., Lee, Y. M., Lee, C., Jung, J., Han, S., & Hong, J. T. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.010 · Cited by 491
McManus, M. J., Murphy, M. P., & Franklin, J. L. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0552-11.2011 · Cited by 432
Neuroprotective strategies involving ROS in Alzheimer disease
Dumont, M., & Beal, M. F. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.026 · Cited by 402
Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values
Dhama, K., Latheef, S. K., Dadar, M., Samad, H. A., Munjal, A. K., Khandia, R., Karthik, K., Tiwari, R., Yatoo, M. I., Bhatt, P., et al. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00091 · Cited by 354
Microbiota from young mice counteracts selective age-associated behavioral deficits
Boehme, M., Guzzetta, K. E., Bastiaanssen, T. F. S., van de Wouw, M., Moloney, G. M., Gual-Grau, A., Spichak, S., Olavarría-Ramírez, L., Fitzgerald, P., Morillas, E., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00093-9 · Cited by 313
Advances in developing novel therapeutic strategies for Alzheimer’s disease
Cao, J., Hou, J., Ping, J., & Cai, D. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0299-8 · Cited by 283
Targeting neuroinflammation in Alzheimer’s disease
Bronzuoli, M. R., Iacomino, A., Steardo, L., & Scuderi, C. (2016) · Journal of Inflammation Research · doi:10.2147/jir.s86958 · Cited by 262
Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment
Mangialasche, F., Polidori, M. C., Monastero, R., Ercolani, S., Camarda, C., Cecchetti, R., & Mecocci, P. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.04.002 · Cited by 250
Vukic, V., Callaghan, D., Walker, D., Lue, L.-F., Liu, Q. Y., Couraud, P.-O., Romero, I. A., Weksler, B., Stanimirovic, D. B., & Zhang, W. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.12.007 · Cited by 232
Fluorescent Diagnostic Probes in Neurodegenerative Diseases
Zhou, J., Jangili, P., Son, S., Ji, M. S., Won, M., & Kim, J. S. (2020) · Advanced Materials · doi:10.1002/adma.202001945 · Cited by 204
An ESIPT Probe for the Ratiometric Imaging of Peroxynitrite Facilitated by Binding to Aβ-Aggregates
Sedgwick, A. C., Dou, W., Jiao, J., Wu, L., Williams, G. T., Jenkins, A. T. A., Bull, S. D., Sessler, J. L., He, X., & James, T. D. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b08457 · Cited by 205
Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer’s disease
Kountouras, J., Boziki, M. K., Gavalas, E., Zavos, C., Grigoriadis, N., Deretzi, G., Tzilves, D., Katsinelos, P., Tsolaki, M., Chatzopoulos, D., et al. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5011-z · Cited by 190
Altered arginine metabolism in Alzheimer's disease brains
Liu, P., Fleete, M. S., Yu, J., Collie, N. D., Curtis, M. A., Waldvogel, H. J., Faull, R. L. M., Abraham, W. C., & Zhang, H. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.013 · Cited by 187
Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress
Akbar, M. D., Essa, M. M., Daradkeh, G., Abdelmegeed, M. A., Choi, Y., Mahmood, L., & Song, B. (2016) · Brain Research · doi:10.1016/j.brainres.2016.02.016 · Cited by 182
Alhasson, F. A., Das, S., Seth, R. K., Dattaroy, D., Chandrashekaran, V., Ryan, C. N., Chan, L. S., Testerman, T. L., Burch, J. B., Hofseth, L. J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172914 · Cited by 152
Dong, Y., Kataoka, K., Tokutomi, Y., Nako, H., Nakamura, T., Toyama, K., Sueta, D., Koibuchi, N., Yamamoto, E., Ogawa, H., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-182873 · Cited by 145
Getting to NO Alzheimer’s Disease: Neuroprotection versus Neurotoxicity Mediated by Nitric Oxide
Balez, R., & Ooi, L. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3806157 · Cited by 149
Primary Cerebral Blood Flow Deficiency and Alzheimer's Disease: Shadows and Lights
Mazza, M., Marano, G., Traversi, G., Bria, P., & Mazza, S. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-090700 · Cited by 130
Blood-brain barrier integrity in the pathogenesis of Alzheimer’s disease
Huang, Z., Wong, L., Su, Y., Huang, X., Wang, N., Chen, H., & Yi, C. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100857 · Cited by 135
Butterfield, D. A., Reed, T. T., & Rukhsana Sultana, A. (2010) · Free Radical Research · doi:10.3109/10715762.2010.520014 · Cited by 125
Nitric Oxide Donors as Neuroprotective Agents after an Ischemic Stroke-Related Inflammatory Reaction
Godínez-Rubí, M., Rojas-Mayorquín, A. E., & Ortuño‐Sahagún, D. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/297357 · Cited by 122
Glial Tau Pathology in Tauopathies: Functional Consequences
Kahlson, M. A., & Colodner, K. J. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s25515 · Cited by 119
L-Arginine and Nitric Oxide in CNS Function and Neurodegenerative Diseases
Virarkar, M., Alappat, L., Bradford, P. G., & Awad, A. B. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.573885 · Cited by 104
Hydrogen sulfide, nitric oxide, and neurodegenerative disorders
Panthi, S., Manandhar, S., & Gautam, K. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0108-x · Cited by 100
Neurotrophic and Neuroprotective Effects of Hericium erinaceus
Szućko-Kociuba, I., Trzeciak-Ryczek, A., Kupnicka, P., & Chlubek, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115960 · Cited by 111
Kim, C., Lee, C., Park, G. H., & Jang, J.-H. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-1609-z · Cited by 96
The Effects of NOS2 Gene Deletion on Mice Expressing Mutated Human AβPP
Colton, C. A., Wilcock, D. M., Wink, D. A., Davis, J., Nostrand, W. E. V., & Vitek, M. P. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15405 · Cited by 92
Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer’s disease
Zuccarello, E., Acquarone, E., Calcagno, E., Argyrousi, E. K., Deng, S., Landry, D. W., Arancio, O., & Fiorito, J. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113818 · Cited by 93
Treatment of Alzheimer’s Disease with a Cholinesterase Inhibitor Combined with Antioxidants
Cornelli, U. (2010) · Neurodegenerative Diseases · doi:10.1159/000295663 · Cited by 90
JIANG, P., Li, C., Xiang, Z., & Jiao, B. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2254 · Cited by 89
Cigliano, L., Spagnuolo, M. S., Crescenzo, R., Cancelliere, R., Iannotta, L., Mazzoli, A., Liverini, G., & Iossa, S. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0518-2 · Cited by 89
Lourenço, C. F., Ledo, A., Barbosa, R. M., & Laranjinha, J. A. N. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.01.013 · Cited by 83
L-arginine and Alzheimer's disease.
Yi, J., Horky, L. L., Friedlich, A. L., Shi, Y., Rogers, J. T., & Huang, X. (2009) · PubMed · Cited by 85
Overlapped Metabolic and Therapeutic Links between Alzheimer and Diabetes
Ahmad, W. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8352-z · Cited by 80
Conformational Altered p53 as an Early Marker of Oxidative Stress in Alzheimer's Disease
Buizza, L., Cenini, G., Lanni, C., Ferrari‐Toninelli, G., Prandelli, C., Govoni, S. M., Buoso, E., Racchi, M., Barcikowska, M., Styczyńska, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029789 · Cited by 81
Redox and Nitric Oxide-Mediated Regulation of Sensory Neuron Ion Channel Function
Gamper, N. L., & Ooi, L. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5884 · Cited by 81
Chaouch, M. A., Hafsa, J., Rihouey, C., Cerf, D. L., & Majdoub, H. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.06.003 · Cited by 75
Research progress of multi-functional fluorescent probes for Alzheimer's disease monitoring
Yang, J., Guo, Y., Pistolozzi, M., & Yan, J. (2021) · Dyes and Pigments · doi:10.1016/j.dyepig.2021.109466 · Cited by 72
Díaz, A., Limón, I. D., Chávez, R., Zenteno, E., & Guevara, J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111979 · Cited by 73
Furini, C. R., Rossato, J. I., Bitencourt, L. L., Medina, J. H., Izquierdo, I., & Cammarota, M. (2010) · Hippocampus · doi:10.1002/hipo.20656 · Cited by 72
Song, B.-J., Abdelmegeed, M. A., Henderson, L. E., Yoo, S.-H., Wan, J., Purohit, V., Hardwick, J. P., & Moon, K.-H. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/781050 · Cited by 67
Quintanilla, R. A., Orellana, J. A., & Rommy von Bernhardi, M. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.10.016 · Cited by 67
Gong, Y., Huang, A., Guo, X., Zhi, J., Chen, X., Zhu, X., Xia, Y., Liu, J., Xu, Y., & Qin, X. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.129345 · Cited by 63
Metformin prevents p-tau and amyloid plaque deposition and memory impairment in diabetic mice
Oliveira, W. H., Braga, C. F., Lós, D. B., Araújo, S. M. R., França, M. R., Duarte-Silva, E., Rodrigues, G. B., Rocha, S. W. S., & Peixoto, C. A. (2021) · Experimental Brain Research · doi:10.1007/s00221-021-06176-8 · Cited by 64
Age-related changes in arginine and its metabolites in memory-associated brain structures
Liu, P., Yu, J. H., & Zhang, H. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.029 · Cited by 63
The in silico and in vivo evaluation of puerarin against Alzheimer's disease
Liu, S., Cao, X., Liu, G.-Q., Zhou, T., Yang, X., & Ma, B.-X. (2019) · Food & Function · doi:10.1039/c8fo01696h · Cited by 62
Ali, M. R. A., Abo‐Youssef, A. M., Messiha, B. A. S., & Khattab, M. M. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1234-6 · Cited by 61
Oh, J. H., Kang, L. L., Ban, J. O., Kim, Y. H., Kim, K. H., Han, S., & Hong, J. T. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.03.014 · Cited by 61
Taupin, P. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147151 · Cited by 62
Gałecki, P., Maes, M. H. J., Florkowski, A., Lewiñski, A., Gałecka, E., Bieńkiewicz, M., & Szemraj, J. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.09.005 · Cited by 59
Nitric oxide mediates glial-induced neurodegeneration in Alexander disease
Wang, L., Hagemann, T. L., Kalwa, H., Michel, T. M., Messing, A., & Feany, M. Β. (2015) · Nature Communications · doi:10.1038/ncomms9966 · Cited by 60
Díaz, A., Mendieta, L., Zenteno, E., Guevara, J., & Limón, I. D. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.12.005 · Cited by 53
Malar, D. S., Shafreen, R. B., Pandian, S. K., & Devi, K. P. (2016) · Pharmaceutical Biology · doi:10.1080/13880209.2016.1241811 · Cited by 52
Hajjo, R., Sabbah, D. A., Abusara, O. H., & Bawab, A. Q. A. (2022) · Diagnostics · doi:10.3390/diagnostics12122975 · Cited by 57
He, X.-L., Zhou, W.-Q., Ming-gang, B., & Du, G. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.084 · Cited by 53
Bergin, D., Yu, J. H., Mockett, B., Zhang, H., Abraham, W. C., & Liu, P. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0149-z · Cited by 52
Nadiga, A. P. R., Suman, & Krishna, K. L. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176332 · Cited by 48
Jung, Y.-S., Kim, D. H., Hwang, J. Y., Yun, N. Y., Lee, Y.-H., Han, S., Hwang, B. Y., Lee, M. S., Jeong, H. S., & Hong, J. T. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.03.001 · Cited by 46
Autotaxin protects microglial cells against oxidative stress
Awada, R., Rondeau, P., Grès, S., Saulnier‐Blache, J. S., d’Hellencourt, C. L., & Bourdon, E. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.014 · Cited by 46
Multi-target neuroprotective effects of herbal medicines for Alzheimer's disease
Fernandes, F., Barroso, M. F., De Simone, A., Emriková, E., Dias-Teixeira, M., Pereira, J. P., Chlebek, J., Fernandes, V. C., Rodrigues, F., Andrisano, V., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115107 · Cited by 45
Neurovascular coupling in Alzheimer patients: Effect of acetylcholine-esterase inhibitors
Rosengarten, B., Paulsen, S., Burr, O., & Kaps, M. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.017 · Cited by 43
S-Nitrosylation of ApoE in Alzheimer’s Disease
Abrams, A. J., Farooq, A., & Wang, G. (2011) · Biochemistry · doi:10.1021/bi200266v · Cited by 43
Zhang, X., Wang, B., Xiao, Y., Wang, C., & He, L. (2018) · The Analyst · doi:10.1039/c8an00905h · Cited by 42
Fernando, C. D., & Soysa, P. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-395 · Cited by 41
Lou, G., ZHANG, Q.-H., Xiao, F., Xiang, Q., Su, Z., Zhang, L., Yang, P., Yang, Y. F., Zheng, Q., & Huang, Y. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.003 · Cited by 40
Ageing alters behavioural function and brain arginine metabolism in male Sprague–Dawley rats
Gupta, N. K., Yu, J. H., Collie, N. D., Zhang, H., & Liu, P. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.013 · Cited by 41
Pre-aggregated Aβ25–35 alters arginine metabolism in the rat hippocampus and prefrontal cortex
Liu, P., Yu, J. H., Collie, N. D., Campbell, S. A., & Zhang, H. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.054 · Cited by 40
Zaręba-Kozioł, M., Szwajda, A., Dadlez, M., Wysłouch-Cieszyńska, A., & Lalowski, M. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.036079 · Cited by 39
“(RNS) play a crucial role in these processes (38).”
BackgroundPang, H.-Y., Liu, G., & Liu, G.-T. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2008.29 · Cited by 39
Manukhina, E. B., Goryacheva, A. V., Barskov, I. V., Викторов, И. В., Guseva, A. A., Pshennikova, M. G., Khomenko, I. P., Mashina, S. Y., Pokidyshev, D. A., & Malyshev, I. Y. (2010) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-010-9320-6 · Cited by 41
Heme oxygenase-1 derived carbon monoxide suppresses Aβ1–42 toxicity in astrocytes
Hettiarachchi, N. T., Boyle, J. P., Dallas, M. L., Al‐Owais, M. M., Scragg, J. L., & Peers, C. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.276 · Cited by 39
Alzheimer’s Disease: A Contextual Link with Nitric Oxide Synthase
Dubey, H., Gulati, K., & Ray, A. (2019) · Current Molecular Medicine · doi:10.2174/1566524019666191129103117 · Cited by 41
Rushaidhi, M., Yu, J. H., Kennard, J. T., Collie, N. D., Williams, J. M., Zhang, H., & Liu, P. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.021 · Cited by 38
McCarty, M. F., Barroso-Aranda, J., & Contreras, F. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.09.058 · Cited by 38
Effects of prolonged agmatine treatment in aged male Sprague–Dawley rats
Rushaidhi, M., Zhang, H., & Liu, P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.004 · Cited by 37
Role of Arginine Guanidinium Moiety in Nitric-oxide Synthase Mechanism of Oxygen Activation
Giroud, C., Moreau, M., Mattioli, T. A., Balland, V., Boucher, J., Li, Y., Stuehr, D. J., & Santolini, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038240 · Cited by 37
Hoos, M. D., Vitek, M. P., Ridnour, L. A., Wilson, J. G., Jansen, M., Everhart, A. L., Wink, D. A., & Colton, C. A. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-50 · Cited by 38
Divergence in the metabolome between natural aging and Alzheimer’s disease
Hunsberger, H. C., Greenwood, B. P., Tolstikov, V., Narain, N. R., Kiebish, M. A., & Denny, C. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-68739-z · Cited by 37
Rodkin, S., Nwosu, C., Sannikov, A., Tyurin, A. V., Чулков, В. С., Raevskaya, M., Ermakov, A. M., Kirichenko, E. Y., & Гасанов, М. З. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076014 · Cited by 41
Age-Related Neurochemical Changes in the Vestibular Nuclei
Smith, P. F. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00020 · Cited by 35
Zhu, G., Guo, M., Zhao, J., Zhang, H., Wang, G., & Chen, W. (2022) · Nutrients · doi:10.3390/nu14040735 · Cited by 35
Parwani, L., Bhatnagar, M., Bhatnagar, A., & Sharma, V. (2013) · Journal of Applied Phycology · doi:10.1007/s10811-013-0180-7 · Cited by 34
Chaouch, M. A., Hafsa, J., Rihouey, C., Cerf, D. L., & Majdoub, H. (2015) · Journal of Food Biochemistry · doi:10.1111/jfbc.12220 · Cited by 34
Kim, S.-J., Lim, J., Kang, S.-K., Lee, Y.-S., & Kang, K. (2008) · Cell Research · doi:10.1038/cr.2008.48 · Cited by 34
M, R. D. S., & P, K. M. P. (2015) · Journal of Nutrition & Food Sciences · doi:10.4172/2155-9600.1000415 · Cited by 33
Pretorius, L., Kell, D. B., & Pretorius, E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00851 · Cited by 36
Hariharan, A., Yu, J., Collie, N. D., Zhang, H., & Liu, P. (2019) · Nitric Oxide · doi:10.1016/j.niox.2019.03.006 · Cited by 34
Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors
Przybyłowska, M., Dzierzbicka, K., Kowalski, S., Chmielewska, K., & Inkielewicz‐Stępniak, I. (2020) · Current Neuropharmacology · doi:10.2174/1570159x19666201218103434 · Cited by 31
The Monkey Head Mushroom and Memory Enhancement in Alzheimer’s Disease
Yanshree, Yu, W. S., Fung, M., Lee, C. W., Lim, L. W., & Wong, K.-H. (2022) · Cells · doi:10.3390/cells11152284 · Cited by 34
Scopolamine impairs behavioural function and arginine metabolism in the rat dentate gyrus
Knox, L. T., Yu, J. H., Fleete, M. S., Collie, N. D., Zhang, H., & Liu, P. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.042 · Cited by 31
Liu, P., Zhang, H., Devaraj, R., Ganesalingam, G. S., & Smith, P. F. (2010) · Hearing Research · doi:10.1016/j.heares.2010.06.019 · Cited by 30
Zhao, J., Cheng, Y., Yang, C., Lau, S., Lao, L., Shuai, B., Cai, J., & Rong, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9195-1 · Cited by 30
Feng, L., Yang, N., Li, C., Tian, G., Wang, J., Dong, Z.-B., Jia, X., & Di, L. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.07.009 · Cited by 29
Agmatine selectively improves behavioural function in aged male Sprague–Dawley rats
Rushaidhi, M., Collie, N. D., Zhang, H., & Liu, P. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.015 · Cited by 29
Nitrative Stress in Cerebral Endothelium is Mediated by mGluR5 in Hyperhomocysteinemia
Mayo, J. N., Beard, R. S., Price, T. O., Chen, C.-H., Erickson, M. A., Nuran Ercal, A., Banks, W. A., & Bearden, S. E. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.185 · Cited by 28
Meiller, A., Sequeira, E., & Marinesco, S. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b03621 · Cited by 29
Metadata
- Authors
- Malinski, T.
- Affiliations
- Department of Chemistry and Biochemistry Ohio University, 350 W. State Street, Athens, OH 45701, USA. Tel.: ; E-mail: malinski@ohio.edu
- Venue
- Journal of Alzheimer s Disease
- Publisher
- SAGE Publications
- Published
- 2007-05-08
- Volume
- 11
- Issue
- 2
- Pages
- 207-218
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1690235847
- Cited by
- 220
- References
- 86
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 8 · 2023: 14 · 2022: 17 · 2021: 12 · 2020: 13 · 2019: 13 · 2018: 15 · 2017: 9 · 2016: 8 · 2015: 9 · 2014: 10 · 2013: 14 · 2012: 10
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- nitric oxide, nitro-oxidative stress
- MeSH terms
- Alzheimer Disease, Humans, Neurons, Nitric Oxide, Amyloid beta-Peptides, Apoptosis, Reactive Oxygen Species, Oxidative Stress, Dexfenfluramine, Peroxynitrous Acid, Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review